alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**UN PUBLISHED** 
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 13**  **- 1959** 

STATE FARM FIRE AND CASUALTY COMPANY , Plaintiff

– Appellee ,
v. CHIJ I OKE AKAMIRO, Default Noted 3/21/2013 , Defendant

– Appellant , and FREDERICK STARKES, Default Noted 3/21/2013 , Defendant
.

Appeal from the United States District Court for the Eastern District of Virginia , at Norfolk
. Mark S. Davis , District Judge. ( 2:13

- cv - 00055

- MSD

- DEM )

Submitted : December 20, 2013 Decided: January 8, 2014

Before WYNN and THACKER , Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by un published per curiam opinion
.
Chi j i oke Akamiro, Appellant Pro Se. Theodore Ira Brenner, BRENNER, EVANS & MILLMAN, PC, Richmond, Virginia, for Appellee.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Chi j i oke Akamiro appeals the district court ’ s order granting State Farm Fire and Casualty Company’s unopposed motion under Fed. R. Civ. P. 55 for a default judgment in this action for a declaratory judgment
. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. State Farm Fire and Cas. Co. v. Akamiro , No. 2:13

- cv - 00055

- MSD

- DEM (E.D. V a. July 19, 2013) . We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before th is court and argument would not aid the decisional
process.
AFFIRMED
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1430 17-Ketosteroids test system. ( a ) *Identification.* A 17-ketosteroids test system is a device intended to measure 17-ketosteroids in urine. Measurements of 17-ketosteroids are used in the diagnosis and treatment of disorders of the adrenal cortex and gonads and of other endocrine disorders, including hypertension, diabetes, and hypothyroidism.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2307, Jan. 14, 2000]
## S IXTH 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________ Case No. 6D 20 2 3

- 3168 Lower Tribunal No. 2 1

- C F

- 6615

_____________________________ S TATE OF F LORIDA , Petitioner ,
v. B RYAN J AMES R ILEY Respondent

.

_____________________________ Petition for Writ of Certiorari to the Circuit Court for Polk County

.

J. Kevin Abdoney, Judge. July 3 , 2024
PER CURIAM.
For the reasons s t at ed in State v. Lobato , 4 9 Fla. L . Weekly D1172 (Fla. 6th DCA May 31, 2024), we grant the petition for writ of certiorari and quash the order
under review.
PETITION FOR CERTIORARI GRANTED; ORDER QUASHED.
STARGEL and GANNAM , JJ., concur. WHITE, J., dissents, with opinion.2 ____________________________ _ NOT FINAL UNTIL TIME EXPIRES TO FILE MOTION FOR REHEARING

AND DISPOSITION THEREOF IF TIMELY FILED

_____________________________
WHITE, J., dissent ing.
I dissent f

or the reasons expressed in State v. Lobato , 4 9 Fla. L . Weekly
D1172 , D1175 (Fla. 6th DCA May 31, 2024) (White, J., dissent ing). 1

_____________________________ Ashley Moody, Attorney General, Tallahassee, and Doris Meacham, Senior Assistant Attorney General, Daytona Beach, for Petitioner

. Howard L. “Rex” Dimmig, II, Public Defender, and Rachel P. Roebuck, Steven L. Bolotin, and Jane A. McNeill, Assistant Public Defender s , Bartow, for R e spond e nt

.

1 Under the circumstances, I dec l ine to adopt the majority opinion in Lobato

. See Normandy Ins. Co. v. Bouayad , 372 S o. 3 d 6 7 1, 695

- 99 (Fla. 1st DCA 2023) ( Tanenbaum, J., concurring in the denial of rehearing en banc )

.
Exhibit 13





Certification Pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of


1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code.





In connection with the Annual Report on Form 20-F of Ellomay Capital Ltd. (the “Company”) for the year ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officers of the Company hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:





A)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





B)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




/s/ Ran FridrichRan FridrichChief Executive Officer/s/ Kalia WeintraubKalia WeintraubChief Financial Officer





Date: April 5, 2012
# C_2014361EN.01003201.xml

| 13.10.2014 | EN | Official Journal of the European Union | C 361/32 |
| --- | --- | --- | --- |

13.10.2014

EN

Official Journal of the European Union

C 361/32

---

Action brought on 15 July 2014 — ZZ v Commission

(Case F-66/14)

2014/C 361/48

Language of the case: French

Parties

Parties

Applicant: ZZ (represented by: S. Orlandi, lawyer)

Applicant:

Defendant: European Commission

Defendant:

Subject-matter and description of the proceedings

Subject-matter and description of the proceedings

Civil Service — Application for a declaration that Article 9 of the General Implementing Provisions (GIPs) of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011 is unlawful and inapplicable and for the annulment of the decision concerning the transfer of the applicant’s pension rights to the European Union pension scheme which applies those new GIPs.

Form of order sought

Form of order sought

| — | Declare that Article 9 of the General Implementing Provisions of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011 is unlawful and, accordingly, inapplicable; |
| --- | --- |

—

Declare that Article 9 of the General Implementing Provisions of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011 is unlawful and, accordingly, inapplicable;

| — | Annul the decision of 4 October 2013 to increase the pension rights acquired by the applicant before her entry into service, on transfer of those rights to the pension scheme of the EU institutions, by application of the GIPs of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011; |
| --- | --- |

—

Annul the decision of 4 October 2013 to increase the pension rights acquired by the applicant before her entry into service, on transfer of those rights to the pension scheme of the EU institutions, by application of the GIPs of Article 11(2) of Annex VIII to the Staff Regulations of 3 March 2011;

| — | Order the Commission to pay the costs. |
| --- | --- |

—

Order the Commission to pay the costs.

---
[Federal Register Volume 75, Number 42 (Thursday, March 4, 2010)]
[Notices]
[Pages 9906-9907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4476]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 9907]]

amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Immunobiology of 
Xenotransplantation.
    Date: March 22-23, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard at Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Jay Bruce Sundstrom, PhD, Scientific Review 
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3119, 
6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-
7042, <a href="/cdn-cgi/l/email-protection#097a7c676d7a7d7b66646349676068606d27676061276e667f"><span class="__cf_email__" data-cfemail="8bf8fee5eff8fff9e4e6e1cbe5e2eae2efa5e5e2e3a5ece4fd">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 24, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-4476 Filed 3-3-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2015279EN.01003501.xml

| 24.8.2015 | EN | Official Journal of the European Union | C 279/35 |
| --- | --- | --- | --- |

24.8.2015

EN

Official Journal of the European Union

C 279/35

---

Judgment of the General Court of 7 July 2015 — Federcoopesca and Others v Commission

(Case T-312/14) (1)

((Application for annulment - Fisheries - Community control system for ensuring compliance with the rules of the common fisheries policy - Commission Decision implementing an action plan aiming at filling gaps in the Italian fisheries control system - Measure not itself modifying the legal situation of the applicant - Not individually affected - Inadmissibility))

(2015/C 279/43)

Language of the case: Italian

Parties

Applicants: Federazione nazionale delle cooperative della pesca (Federcoopesca) (Rome, Italy); Associazione Lega Pesca (Rome); Associazione generale cooperative italiane settore agro ittico alimentare (AGCI AGR IT AL) (Rome) (represented by: L. Caroli, S. Ventura and V. Cannizzaro, lawyers)

Defendant: European Commission (represented by: A. Bouquet and D. Nardi, acting as Agents)

Re:

Application for annulment of Commission Decision C (2013) 8635 final of 6 December 2013 concerning an action plan implementing aiming at filling gaps in the Italian fisheries control system.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders the Federazione nazionale delle cooperative della pesca (Federcoopesca), Associazione Lega Pesca and Associazione generale cooperative italiane settore agro ittico alimentare (AGCI AGR IT AL) to pay the costs. |
| --- | --- |

2.

Orders the Federazione nazionale delle cooperative della pesca (Federcoopesca), Associazione Lega Pesca and Associazione generale cooperative italiane settore agro ittico alimentare (AGCI AGR IT AL) to pay the costs.

---

(1)  
  OJ C 194, 24.6.2014.

---
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 01-40437

Conference Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

ABRAHAM GARCIA-AGUILERA,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Southern District of Texas

USDC No. C-00-CR-350-1

--------------------

December 12, 2001

Before HIGGINBOTHAM, BARKSDALE, and STEWART, Circuit Judges.

PER CURIAM:*

The Federal Public Defender appointed to represent Abraham

Garcia-Aguilera has moved for leave to withdraw and has filed a

brief as required by Anders v. California, 386 U.S. 738 (1967). 

Garcia-Aguilera has received a copy of counsel’s brief and motion

but has not filed a response. Our independent review of

counsel’s Anders brief and the record discloses no nonfrivolous

issue for appeal. Accordingly, counsel’s motion for leave to

withdraw is GRANTED, counsel is excused from further

responsibilities herein, and the APPEAL IS DISMISSED.

5TH CIR. R. 42.2.
# C_2015294EN.01005901.xml

| 7.9.2015 | EN | Official Journal of the European Union | C 294/59 |
| --- | --- | --- | --- |

7.9.2015

EN

Official Journal of the European Union

C 294/59

---

Order of the General Court of 9 June 2015 — Kronotex and Kronoply v Commission

(Case T-236/14) (1)

1

((State aid - Measures adopted by Germany in favour of electricity generated from renewable energy sources and of energy-intensive undertakings - Decision to open the procedure under Article 108(2) TFEU - Adoption of the final decision after the action was brought - No need to adjudicate))

(2015/C 294/71)

Language of the case: German

Parties

Parties

Applicants: Kronotex GmbH & Co. KG (Heiligengrabe, Germany); and Kronoply GmbH (Heiligengrabe, Germany) (represented by: H. Janssen and G.-R. Engel, lawyers)

Applicants:

Defendant: European Commission (represented by: T. Maxian Rusche and R. Sauer, acting as Agents, and by A. Luke and C. Maurer, lawyers)

Defendant:

Re:

Re:

Application to annul in part Commission decision C (2013) 4424 final of 18 December 2013 to open the procedure under Article 108(2) TFEU regarding measures implemented by the Federal Republic of Germany in favour of renewable electricity and of energy-intensive users (State aid SA.33995 (2013/C) (ex 2013/NN)).

Operative part of the order

Operative part of the order

| 1. | There is no longer any need to adjudicate on the present action. |
| --- | --- |

1.

There is no longer any need to adjudicate on the present action.

| 2. | There is no longer any need to adjudicate on the application for intervention submitted by the EFTA Surveillance Authority. |
| --- | --- |

2.

There is no longer any need to adjudicate on the application for intervention submitted by the EFTA Surveillance Authority.

| 3. | Kronetex GmbH & Co. KG and Kronoply GmbH shall bear their own costs and those incurred by the European Commission. |
| --- | --- |

3.

Kronetex GmbH & Co. KG and Kronoply GmbH shall bear their own costs and those incurred by the European Commission.

| 4. | The EFTA Surveillance Authority shall bear its own costs. |
| --- | --- |

4.

The EFTA Surveillance Authority shall bear its own costs.

---

(1)  OJ C 223, 14.7.2014.

1

---
#### § 558.365 Neomycin sulfate.

(a) *Specifications.* Type A medicated article containing 325 grams neomycin sulfate per pound.

(b) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.

(c) *Related tolerances.* See § 556.430 of this chapter.

(d) *Special considerations.*

(1) Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian. See § 558.6 for additional requirements.

(2) The expiration date of VFDs for neomycin medicated feeds must not exceed 6 months from the date of issuance. VFDs for neomycin shall not be refilled.

(e) *Conditions of use.* Neomycin sulfate is used as follows:

| Neomycin Sulfate | Combination | Indications for Use | Limitations | Sponsor |
| --- | --- | --- | --- | --- |
| (1) 250 to 2,250 grams per ton (g/t) of dry type C feed. | | Cattle, swine, sheep, and goats. For treatment and control of colibacillosis (bacterial enteritis) caused by *Escherichia coli* susceptible to neomycin. | To provide 10 milligrams (mg) of neomycin sulfate per pound of body weight per day for a maximum of 14 days. The concentration of neomycin sulfate required in medicated feed must be adjusted to compensate for variation in age and weight of animal, the nature and severity of disease signs, and environmental temperature and humidity, each of which affects feed consumption. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter as follows: Cattle 1 day, swine 3 days, sheep 2 days, and goats 3 days. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle or lactating dairy goats. Do not use in female dairy cattle 20 months of age or older or female dairy goats 12 months of age or older. For use in dry feeds only. Not for use in liquid feed supplements. | 054771 |
| (2) 400 to 2,000 g/t of type C milk replacer. | | Do. | To provide 10 mg of neomycin sulfate per pound of body weight per day for a maximum of 14 days. Amount consumed will vary depending on animal's consumption and weight. If symptoms persist after using for 2 or 3 days, consult a veterinarian. Treatment should continue 24 to 48 hours beyond remission of disease symptoms. Discontinue treatment prior to slaughter as follows: Cattle 1 day, swine 3 days, sheep 2 days, and goats 3 days. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. A milk discard time has not been established for use in lactating dairy cattle or lactating dairy goats. Do not use in female dairy cattle 20 months of age or older or female dairy goats 12 months of age or older. For use in milk replacers only. | 054771 |

[64 FR 70576, Dec. 17, 1999, as amended at 65 FR 45881, July 26, 2000; 79 FR 13545, Mar. 11, 2014; 81 FR 95009, Dec. 27, 2016. Redesignated at 83 FR 64742, Dec. 18, 2018]
EXHIBIT 10.12

                                 PROMISSORY NOTE

$10,000.00                        Dallas, Texas                  January 5, 1999

         FOR VALUE  RECEIVED,  Preferred  Voice,  Inc.,  a Delaware  corporation
promises to pay to the order of Bisbro  Investments  Co. Ltd., at P.O. Box 3444,
Road Town,  Tortola,  British  Virgin  Islands,  or at such other address as the
holder  hereof  may  designate,  the  principal  sum  of  Ten  Thousand  Dollars
($10,000.00),  together with interest on the unpaid  principal  balance from the
date hereof until this note is paid in full at a rate of 10% per annum.

         Principal and interest  shall be payable in one  installment on January
5, 2000.

         All payments  received shall be applied first to the payment of accrued
interest and then to the payment of principal.

         Maker shall have the right to prepay any and all amounts due  hereunder
without penalty for the privilege of doing so.

         No payment shall be considered in default  unless it is not paid within
ten (10) days after delivery of written notice of nonpayment.

         Holder will have the right at any time to convert this note into shares
of common stock,  $.001 par value per share, of Maker, at the conversion rate of
one share of common  stock for each $.50 of  principal  and  interest due on the
note on the date of conversion.

         In the event  default is made in the  payment of this Note,  the unpaid
balance on this Note shall at once become due and payable,  without  notice,  at
the option of the Holder. Failure to exercise this option shall not constitute a
waiver of the right to declare the entire  principal  due and payable at once at
any subsequent time.

         If, after default,  this Note is placed in the hands of an attorney for
collection,  or if collected  through judicial  proceeding,  Maker shall pay, in
addition to the sums  referred to above,  a reasonable  sum as a  collection  or
attorneys'  fee and all other  costs  incurred  by Holder in  collection  of the
unpaid amounts due hereunder.

         Each maker, surety,  guarantor,  endorser or other party liable for the
payment of this Note, in whole or in part,  hereby expressly waives  presentment
and demand for payment,  notice of intention to accelerate  maturity,  notice of
acceleration of maturity, protest and notice of protest and nonpayment, bringing
of suit and  diligence  in taking any action to collect sums owing  hereon,  and
agree that this Note,  and any payment  hereunder,  may be extended from time to
time without in any way affecting such liability,

MAKER:

Preferred Voice, Inc.


-----------------------
Ray Miller
Its: President
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7665 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7665

  To amend title XVIII of the Social Security Act to improve the way 
beneficiaries are assigned under the Medicare shared savings program by 
also basing such assignment on primary care services furnished by nurse 
  practitioners, physician assistants, and clinical nurse specialists.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 13, 2024

 Mr. Kilmer (for himself, Mr. Smith of Nebraska, Ms. DelBene, and Mr. 
  Gallagher) introduced the following bill; which was referred to the 
Committee on Ways and Means, and in addition to the Committee on Energy 
    and Commerce, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
  To amend title XVIII of the Social Security Act to improve the way 
beneficiaries are assigned under the Medicare shared savings program by 
also basing such assignment on primary care services furnished by nurse 
  practitioners, physician assistants, and clinical nurse specialists.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``ACO Assignment Improvement Act of 
2024''.

SEC. 2. IMPROVEMENTS TO THE ASSIGNMENT OF BENEFICIARIES UNDER THE 
              MEDICARE SHARED SAVINGS PROGRAM.

    Section 1899(c)(1) of the Social Security Act (42 U.S.C. 
1395jjj(c)(1)) is amended--
            (1) in subparagraph (A), by striking ``and'' at the end;
            (2) in subparagraph (B), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following new subparagraph:
                    ``(C) in the case of performance years beginning on 
                or after January 1, 2025, primary care services 
                provided under this title by an ACO professional 
                described in subsection (h)(1)(B).''.
                                 <all>
```